MEPTIC founded in 2002 as a non-profit, non-governmental, and science-based institute. The first foundation was based as a research-based company. We provide medical journalism services to journals.
We are an affiliated publishing consultant of International Virtual Ophthalmic Research Center
As one of the publishers of peer-reviewed scholarly journals, we succeed to publish ‘Medical Hypothesis, Discovery & Innovation Ophthalmology Journal’. This journal is currently indexed at (Listed in alphabetical order): Chemical Abstracts, Genomics journal seek, Google Scholar, Hinari, World Health Organization, Index Copernicus, ISC, Journal TOCs, PKP Open Archives Harvester, ProQuest, PubMed Central, PubsHub, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Central, ProQuest Nursing & Allied Health Database, ProQuest Pharma Collection, RoMEO, OCLC WorldCat Discovery Service, and Ulrich’s.
We are organizing medical journalism workshops worldwide e.g. the workshops at World Ophthalmology Congress. For example, we provided multiple presentations focus on “Detection and Management of Fraud and Plagiarism in Publications” as well as “Pearls to Publish a Study in High Impact Journals”.
With regards to our 18 years of experiences in the field of medical journalism, we would provide a number of professional publishing services including web hosting, CMS, database, online repository, archiving, XML conversion, reference formatting, unlimited number of color figures, and English editing.
Medical Journalism Services
We endorses the World Association of Medical Editors (WAME) policies in Editorial, Peer Review, Advertisement, Ethics, Informed Consent, handling cases requiring corrections, retractions, and editorial expressions of concern. We also respect to polices of International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
All submissions at our journal undergo a peer-review process performed by at least two reviewers. These reviewers are expert in their fields. The final decision could be as accepted, minor or major revision or fast rejection. 1. Language, originality, reliability, statistical validity and relevance are important factors for reviewers. 2. There is no warranty to accept the manuscript if authors are encouraged to revise and resubmit the manuscript. 3. It is of noteworthy that rejected manuscripts would not be re-reviewed unless extremely rare circumstances. 4. Acceptance considers legal provisions including plagiarism and copyright infringement. All authors should declare that their paper is their own original research. However, they must warranty reality and authenticity of their data. Also they must declare that their paper has not been published elsewhere before, or even submitted and under review in another journal. However, they shall participate in the peer review process. The corresponding author takes primary responsibility for communication with the journal office during all steps and follows the ethical principles in publication. The corresponding author should respond to editorial office and should cooperate with any requests from the journal after publication. Our Journal does not allow adding/deleting authors or changing the orders of authors following the final acceptance. All authors must follow the rules for authorship mentioned above and declare their financial interest. Acknowledgment should be clearly declared in all submissions. All conflict of interests must be mentioned exactly the same as all resources that helped performing their research work. Conflict of interests include (but are not limited to):
· Research grants from funding agencies (The research funder and the grant number are required),
· Financial support for educational programs,
· Employment or consultation,
· Position on advisory board or board of directors or other types of management relationships,
· Financial relationships, for example, receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future,
· Intellectual property rights (e.g. patents, copyrights and royalties from such rights),
· Holdings of spouse and/or children that may have financial interest in the work
An informed written consent should be obtained from all participants or their legal parties. The name of the review board that approved the work must be mentioned in the manuscript. All animal research should respect to Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines (https://www.nc3rs.org.uk/arrive-guidelines). The authors should follow Declaration of Helsinki in medical research involving human subjects. Authors should guarantee the integrity of reported data. Ethical issues should be completely observed by the authors. All named authors must meet the ICMJE criteria for authorship, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published. Finally, the corresponding author signs the copyright agreement on behalf of co-authors. The ICMJE recommends that authorship is based on the followings: “1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2. Drafting the work or revising it critically for important intellectual content; AND 3. Final approval of the version to be published; AND 4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work is appropriately investigated and resolved.” The authors must consider all ethical regulations of ICMJE as well as these ethical regulations: 1. Declaration of interests: funding that helped you must be mentioned. 2. Registering clinical trials: there are international and national trusted registries to register clinical trials. 3. Respecting confidentiality: patients’ information should be kept secret and anonymous. Also, protecting patient or animal rights under investigation is of great importance. The welfare of animals used for research must be respected. As mentioned, authors should obtain ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment. Authors should proceed to register the trials registries & bear a clinical trial registration number. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT guidline. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from a different journal that is not open access.
Peer Review Policy
All submissions undergo a peer-review process. All data in the manuscript regarding subjects must be kept secret by the reviewers. Author(s) may present list names of potential reviewers when submitting a publication, however selection remains the editor decision. No personal criticism of the author should be involved in the review of the manuscript. Knowing the author should not affect the process of reviewing and decision making. Relevant previously published articles must be identified by the reviewer if not cited in the references. Also, any similarity regarding data or method with other previously published manuscripts must be reported to the Editor-in-Chief. However, if there is any conflict of interest between the reviewer and the authors, the manuscript must be edited by another reviewer.
Advertisements are independent of editorial decisions. We will reject advertisements that seem to be unsafe to health, as well as transmit to the content of a racial, ethnic, sexual, or religious issues. All advertisements for drug-related contents should inspire rational use and must not be misleading in nature. Furthermore, editorial decisions and publisher assignments will not be predisposed by an advertisement and sponsors. The publisher has the right to withdraw drug-specific targeted campaign to be linked in a specific article. All inquiries will review at Advertising Standards Committee at publisher office.
Research Ethics Policy
Ethics and Malpractice Statement: We follow the rules and regulations released by the “International Committee of Medical Journal Editors (ICMJE)” including all aspects regarding the conduct of research, how to report a research, style, edit, and finally publishing the manuscript. Hence, it is strongly recommended if author(s) read these recommendations prior to submission (http://www.icmje.org). If there is any plagiarism or misconduct detected in data or publication, the editors have the right to inform the author or affiliated institute and act based on the COPE (Committee on Publication Ethics) guidelines (https://publicationethics.org/core-practices). Conflict of interest happens when there is a personal or financial association between any part in publication process such as authors, reviewers, or editors of journals which could lead to any disturbance in performing their roles. Therefore, based on the ICMJE rules, any conflict of interest should be reported in a special format for consideration by the editors. ICMJE rules must be obeyed by all the editorial members, reviewers and authors. The Journal is the member of WAME and ICMJE at present in view of publication and ethical principles. The editorial board will incessantly work towards observing publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical problem with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and etc. When the journal faces suspected cases of research and publication misconduct, the resolving process will be followed by guidelines provided by the “Committee on Publication Ethics (COPE)”
Informed Consent Policy
In articles with the samples from human, the informed consent and ethical approval should be clearly mentioned in the “Materials and Methods” section. The author should also embrace that all experiments (human or animals) were performed in compliance with the relevant institutional guidelines, and also should state the institutional committee(s) that has approved the study. We highly suggest endorsing policies of WAME and ICMJE as well as the World Health Organization in these important issues.
Handling cases requiring corrections, retractions, and editorial expressions of concern
We respect to research integrity, therefore, a research integrity officer and committee has been assigned at our center. Corrections or retractions of published articles will be made by publishing a correction or retraction note. In this way, the original article remains in the public and the subsequent note will publish. The decision to publish the correction/retraction is based on the COPE guidelines.
Send Us a Message
MEPTIC – All rights reserved 2020 – Image Credit: Pixabay